Home Biogen Idec And Swedish Orphan Biovitrum Announce European Medicines...
 

Keywords :   


Biogen Idec And Swedish Orphan Biovitrum Announce European Medicines...

2014-11-04 04:36:32| Appliances - Topix.net

CAMBRIDGE, Mass. & STOCKHOLM-- --Biogen Idec and Swedish Orphan Biovitrum AB today announced that the European Medicines Agency has validated the Marketing Authorization Application of ELOCTATM , a recombinant factor VIII Fc fusion protein product candidate for the treatment of hemophilia A. The validation of the MAA initiates the EMA's review process.

Tags: european swedish announce medicines

Category:Consumer Goods and Services

Latest from this category

All news

23.11'Trust and reserve judgement' on rebrand, says Jaguar
23.11UK wants to hire EU negotiator to 'reset' relations
23.11Sisters build global beauty brand from a garage
23.11Versace bag for 15: Why Christmas shoppers are choosing charity shops
23.11'We are being robbed': Homeowners feel trapped by rising fees
22.11'Scammers sent courier to steal 4,000'
22.11Spain fines budget airlines including Ryanair 179m
22.11Formulating Biphasic and Triphasic Products
Consumer Goods and Services »
24.111000 15
24.11 nike soccer usa national team uniform
24.1160266
24.11 1
24.11
24.11GREATEST HITS ALTER EGO EGOIST
24.11(ALINCO)
24.11[]34
More »